SEC Form 4 · accession 0001424422-19-000001
BioPharmX Corp · BPMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anja B Krammer
Director
Period of report
Jan 23, 2019
Accepted (ET)
Jan 25, 2019 · 6:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504167
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Jan 23, 2019 | S | 115,874 | $0.11 | D | 1,884,126 | D |
Table II — derivative securities
No Table II lines on this filing.